Dolezalova, Nikola
Gruszczyk, Anja
Barkan, Kerry
Gamble, John A.
Galvin, Sam
Moreth, Till
O’Holleran, Kevin
Mahbubani, Krishnaa T.
Higgins, Jackie A.
Gribble, Fiona M.
Reimann, Frank
Surmacki, Jakub
Andrews, Simon
Casey, John J.
Pampaloni, Francesco
Murphy, Michael P.
Ladds, Graham
Slater, Nigel K. H.
Saeb-Parsy, Kourosh
Funding for this research was provided by:
W. D. Armstrong Fund
MRC UK (MC_U105663142)
Wellcome Trust Investigator award (110159/A/15/Z)
Leverhulme Trust (RPG-2017-255)
BBSRC iCASE PhD studentship partnered with AstraZeneca, Wellcome Trust (106262/Z/14/Z)
Medical Research Council (MRC) Metabolic Diseases Unit (MRC_MC_UU_12012/3)
MRC “Enhancing UK clinical research” grant (MR/M009041/1)
EU Horizon2020 project LSFM4LIFE (668350-2)
Article History
Received: 10 January 2021
Accepted: 22 April 2021
First Online: 17 May 2021
Competing interests
: The authors declare no competing interests.